We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSF
4201
DELISTED
VictoryShares US Discovery Enhanced Volatility Wtd ETF
CSF
$8K ﹤0.01%
200
GHSI
4202
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$8K ﹤0.01%
127
-22
-15% -$2.28K
MMAT
4203
DELISTED
Meta Materials Inc. Common Stock
MMAT
$8K ﹤0.01%
150
-350
-70% -$21.6K
TPHS
4204
DELISTED
Trinity Place Holdings Inc.com
TPHS
$8K ﹤0.01%
6,298
+5,525
+715% +$7.78K
BIOL
4205
DELISTED
Biolase, Inc.
BIOL
$8K ﹤0.01%
+11
New +$10.3K
AEY
4206
DELISTED
ADDvantage Technologies Group
AEY
$8K ﹤0.01%
429
+278
+184% +$6.41K
BBIG
4207
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$8K ﹤0.01%
333
+227
+214% +$8.74K
IBA
4208
DELISTED
Industrias Bachoco SAB De C.V.
IBA
$8K ﹤0.01%
214
-243
-53% -$8.97K
ATCO
4209
DELISTED
Atlas Corp.
ATCO
$8K ﹤0.01%
988
-6,734
-87% -$54.7K
FSTX
4210
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$8K ﹤0.01%
1,553
-406
-21% -$2.43K
HZN
4211
DELISTED
Horizon Global Corporation
HZN
$8K ﹤0.01%
1,320
-15,143
-92% -$73.4K
USWS
4212
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$8K ﹤0.01%
1,397
+1,152
+470% +$8.75K
GSV
4213
DELISTED
Gold Standard Ventures Corp.
GSV
$8K ﹤0.01%
+9,911
New +$8.43K
FCACU
4214
DELISTED
Falcon Capital Acquisition Corp. Unit
FCACU
$8K ﹤0.01%
+800
New +$8.23K
HWCC
4215
DELISTED
Houston Wire & Cable Company
HWCC
$8K ﹤0.01%
3,120
+3,095
+12,380% +$8.13K
SYNC
4216
DELISTED
Synacor, Inc.
SYNC
$8K ﹤0.01%
+5,270
New +$6.41K
PE
4217
DELISTED
PARSLEY ENERGY INC
PE
$8K ﹤0.01%
863
-41,990
-98% -$449K
ACR
4218
ACRES Commercial Realty
ACR
$101M
$7K ﹤0.01%
1,110
-3,306
-75% -$22.9K
ALLT icon
4219
Allot
ALLT
$388M
$7K ﹤0.01%
751
-72
-9% -$761
AQMS icon
4220
Aqua Metals
AQMS
$10.1M
$7K ﹤0.01%
39
-52
-57% -$10.8K
ARMP icon
4221
Armata Pharmaceuticals
ARMP
$177M
$7K ﹤0.01%
2,270
+173
+8% +$609
BEEM icon
4222
Beam Global
BEEM
$25.5M
$7K ﹤0.01%
+563
New +$7.08K
CEF icon
4223
Sprott Physical Gold and Silver Trust
CEF
$8.17B
$7K ﹤0.01%
364
+50
+16% +$960
CLRB icon
4224
Cellectar Biosciences
CLRB
$19.8M
$7K ﹤0.01%
19
-7
-27% -$2.77K
CLS icon
4225
Celestica
CLS
$43.8B
$7K ﹤0.01%
1,060
-3,105
-75% -$23.3K

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.